These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6099336)

  • 1. Solid phase synthesis of retro-inverso peptide analogues. Synthesis and biological activity of the partially modified retro-inverso analogue of the bradykinin potentiating peptide BPP9a [gLys6, (RS)-mPhe7, Ala8] BPP9a.
    Bonelli F; Pessi A; Verdini AS
    Int J Pept Protein Res; 1984 Dec; 24(6):553-6. PubMed ID: 6099336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK; Juliano L
    Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages.
    Arcoleo F; Milano S; D'Agostino P; Misiano G; Cappelletti S; Gromo G; Marcucci F; Leoni F; Cillari E
    Br J Pharmacol; 1997 Apr; 120(7):1383-9. PubMed ID: 9105716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.
    Bakhle YS
    Br J Pharmacol; 1977 Jan; 59(1):123-8. PubMed ID: 189870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
    Rodrigues MS; Schaffel R; Assreuy J
    Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure and conformation of partially-modified retro- and retro-inverso psi[NHCH(CF3)]Gly peptides.
    Volonterio A; Bellosta S; Bravin F; Bellucci MC; Bruché L; Colombo G; Malpezzi L; Mazzini S; Meille SV; Meli M; Ramírez De Arellano C; Zanda M
    Chemistry; 2003 Sep; 9(18):4510-22. PubMed ID: 14502637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for kininase II inhibition by lower homologs of the bradykinin potentiating peptide BPP9a.
    Fisher GH; Ryan JW; Martin LC; Pena GA
    Adv Exp Med Biol; 1979; 120B():651-63. PubMed ID: 229714
    [No Abstract]   [Full Text] [Related]  

  • 10. Bradykinin analogs as inhibitors of angiotensin-converting enzyme.
    Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS
    Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAcSDKP analogues resistant to angiotensin-converting enzyme.
    Gaudron S; Adeline MT; Potier P; Thierry J
    J Med Chem; 1997 Nov; 40(24):3963-8. PubMed ID: 9397177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
    Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
    J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
    Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
    Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional studies on Ribonuclease S, retro S and retro-inverso S peptides.
    Pal-Bhowmick I; Pandey RP; Jarori GK; Kar S; Sahal D
    Biochem Biophys Res Commun; 2007 Dec; 364(3):608-13. PubMed ID: 17963728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo T helper cell response to retro-inverso peptidomimetics.
    Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
    J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a bradykinin potentiating nonapeptide (BPP9a) on prolonged haemorrhagic shock in dogs.
    Errington ML; Rocha e Silva Júnior M
    J Physiol; 1973 Aug; 233(1):46P-47P. PubMed ID: 4357201
    [No Abstract]   [Full Text] [Related]  

  • 17. Fate of bradykinin-potentiating peptide 9a after intravenous injection.
    Martin LC; Ryan JW; Fisher GH; Chung A; Epstein M; Stewart JM
    Biochem J; 1979 Dec; 184(3):713-6. PubMed ID: 540061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs.
    Fernandez JH; Neshich G; Camargo AC
    Genet Mol Res; 2004 Dec; 3(4):554-63. PubMed ID: 15688321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.
    Fernandes PD; Guimarães JA; Assreuy J
    Agents Actions; 1991 Mar; 32(3-4):182-7. PubMed ID: 1862741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a bradykinin potentiating peptide (BPP-S) isolated from Scaptocosa raptoria venom.
    Ferreira LA; Alves WE; Lucas MS; Habermehl GG
    Toxicon; 1996 May; 34(5):599-603. PubMed ID: 8783454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.